Lauren Maslin, Ph.D.

Lauren Maslin is an Analyst at Catalio Capital Management L.P.

Her technical expertise is in the field of immuno-oncology where she studied the immunomodulatory effects of targeted therapies to better identify rational drug combinations in gastrointestinal (GI) cancers.

Lauren earned a B.S. in both Biochemistry and Molecular Biology and Genetics from the University of Georgia and a Ph.D. in Cellular and Molecular Medicine from Johns Hopkins School of Medicine.

MEMBER OF Investment Committee

Associated Portfolio Companies

No items found.